Ibandronate Sodium

Cat. No.: HY-B0515B: FAQs
Data Sheet Handling Instructions

Molarity Calculator

Ibandronate sodium is a highly active nitrogen-containing bisphosphonate that can be used for osteoporosis.

For research use only. We do not sell to patients.

Ibandronate Sodium Chemical Structure

CAS No. : 138844-81-2

Size		Stock
MOQ		Minimum order quantity
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote
Other size		Get quote

Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of Ibandronate Sodium:

Ibandronate Sodium Monohydrate

Other Forms of Ibandronate Sodium:

Ibandronate Sodium Monohydrate In-stock
Ibandronic acid Get quote

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Ibandronate sodium is a highly active nitrogen-containing bisphosphonate that can be used for osteoporosis.

Clinical Trial

Molecular Weight

341.21

Formula

C₉H₂₂NNaO₇P₂

CAS No.

138844-81-2

SMILES

OC(P(O)(O)=O)(P(O)([O-])=O)CCN(C)CCCCC.[Na+]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Handling Instructions (2659 KB)

References

[1]. Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78(3): p. 453-8. [Content Brief]

[2]. Epplen, R., et al., Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol, 2011. 50(1): p. 127-33. [Content Brief]

[3]. Chesnut, I.C., et al., Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res, 2004. 19(8): p. 1241-9. [Content Brief]

[4]. Bauss, F., et al., Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol, 2002. 29(10): p. 2200-8. [Content Brief]